| Elizabeth Anne Lauten, DPT, BA, MDIV | |
|
613 Hickory St Nw, Albany, OR 97321-1752 | |
| (541) 928-1411 | |
| (541) 928-7044 |
| Full Name | Elizabeth Anne Lauten |
|---|---|
| Gender | Female |
| Speciality | Physical Therapy |
| Experience | 5 Years |
| Location | 613 Hickory St Nw, Albany, Oregon |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1134774573 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 225100000X | Physical Therapist | 63343 (Oregon) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Corvallis Sport And Spine Physical Therapy Inc | 2961469333 | 10 |
News Archive
Wait times in U.S. emergency departments are increasing. A new study published in Economic Inquiry indicates that prolonging the wait time in the emergency department for a patient who arrives with a serious condition by 10 minutes will increase the hospital's cost to care for the patient by an average of 6%, and it will increase the cost to care for moderately severe cases by an average of 3%.
Physicians often find it hard to tell if a patient suffering from dementia or depression is capable of making sound judgements. This is shown by a study conducted within the scope of the National Research Programme "End of Life" (NRP 67). The Central Ethics Committee of the Swiss Academy of Medical Sciences now aims to elaborate new assessment principles.
If you were dying from cancer, would you consider genetic testing. A recent study conducted by researchers from Virginia Commonwealth University Massey Cancer Center showed that most terminally ill cancer patients who were eligible for genetic testing never received it despite that it could potentially save a relative's life.
Today, the U.S. Food and Drug Administration approved Breyanzi (lisocabtagene maraleucel), a cell-based gene therapy to treat adult patients with certain types of large B-cell lymphoma who have not responded to, or who have relapsed after, at least two other types of systemic treatment.
Today Ingenuity Systems and CLC bio announced that they're collaborating to provide interoperability between their software solutions. The aim of the partnership is to provide researchers with the ability to easily exchange data between CLC bio's enterprise and desktop solutions and Ingenuity's pathway analysis software (IPA®), in order to perform both array and next-generation sequencing data and knowledge analyses.
› Verified 8 days ago
| Provider Name | Corvallis Sport And Spine Physical Therapy Inc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1841388170 PECOS PAC ID: 2961469333 Enrollment ID: O20041216001051 |
News Archive
Wait times in U.S. emergency departments are increasing. A new study published in Economic Inquiry indicates that prolonging the wait time in the emergency department for a patient who arrives with a serious condition by 10 minutes will increase the hospital's cost to care for the patient by an average of 6%, and it will increase the cost to care for moderately severe cases by an average of 3%.
Physicians often find it hard to tell if a patient suffering from dementia or depression is capable of making sound judgements. This is shown by a study conducted within the scope of the National Research Programme "End of Life" (NRP 67). The Central Ethics Committee of the Swiss Academy of Medical Sciences now aims to elaborate new assessment principles.
If you were dying from cancer, would you consider genetic testing. A recent study conducted by researchers from Virginia Commonwealth University Massey Cancer Center showed that most terminally ill cancer patients who were eligible for genetic testing never received it despite that it could potentially save a relative's life.
Today, the U.S. Food and Drug Administration approved Breyanzi (lisocabtagene maraleucel), a cell-based gene therapy to treat adult patients with certain types of large B-cell lymphoma who have not responded to, or who have relapsed after, at least two other types of systemic treatment.
Today Ingenuity Systems and CLC bio announced that they're collaborating to provide interoperability between their software solutions. The aim of the partnership is to provide researchers with the ability to easily exchange data between CLC bio's enterprise and desktop solutions and Ingenuity's pathway analysis software (IPA®), in order to perform both array and next-generation sequencing data and knowledge analyses.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Elizabeth Anne Lauten, DPT, BA, MDIV 2635 Nw Rolling Green Dr, Corvallis, OR 97330-3519 Ph: (541) 753-4246 | Elizabeth Anne Lauten, DPT, BA, MDIV 613 Hickory St Nw, Albany, OR 97321-1752 Ph: (541) 928-1411 |
News Archive
Wait times in U.S. emergency departments are increasing. A new study published in Economic Inquiry indicates that prolonging the wait time in the emergency department for a patient who arrives with a serious condition by 10 minutes will increase the hospital's cost to care for the patient by an average of 6%, and it will increase the cost to care for moderately severe cases by an average of 3%.
Physicians often find it hard to tell if a patient suffering from dementia or depression is capable of making sound judgements. This is shown by a study conducted within the scope of the National Research Programme "End of Life" (NRP 67). The Central Ethics Committee of the Swiss Academy of Medical Sciences now aims to elaborate new assessment principles.
If you were dying from cancer, would you consider genetic testing. A recent study conducted by researchers from Virginia Commonwealth University Massey Cancer Center showed that most terminally ill cancer patients who were eligible for genetic testing never received it despite that it could potentially save a relative's life.
Today, the U.S. Food and Drug Administration approved Breyanzi (lisocabtagene maraleucel), a cell-based gene therapy to treat adult patients with certain types of large B-cell lymphoma who have not responded to, or who have relapsed after, at least two other types of systemic treatment.
Today Ingenuity Systems and CLC bio announced that they're collaborating to provide interoperability between their software solutions. The aim of the partnership is to provide researchers with the ability to easily exchange data between CLC bio's enterprise and desktop solutions and Ingenuity's pathway analysis software (IPA®), in order to perform both array and next-generation sequencing data and knowledge analyses.
› Verified 8 days ago
Amber Fleming, PT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 3615 Spicer Dr Se, Albany, OR 97322 Phone: 541-967-7551 | |
Jessica Anne Reich, DPT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 2853 Salem Ave Se, Albany, OR 97321 Phone: 541-223-9854 | |
Mr. Brad Boylan, ATC, PT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 3705 Columbus St Se, Albany, OR 97322 Phone: 541-967-4522 | |
Christina Colleen Blohm, DPT Physical Therapist Medicare: Medicare Enrolled Practice Location: 613 Hickory St Nw, Albany, OR 97321 Phone: 541-928-1411 | |
Ms. Julianne W. Howell, PT, MS, CHT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 920 29th Ave Sw, Albany, OR 97321 Phone: 541-812-4920 Fax: 541-812-4929 | |
Mr. Gregory F Pick, PHYSICAL THERAPIST Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 1325 Waverly Dr Se, Albany, OR 97322 Phone: 541-967-1224 Fax: 541-967-2750 |